ALNYLAM PHARMACEUTICALS, INC. Accounts Payable 2009-2025 | ALNY
What is accounts payable?
Accounts payable represents money the company owes to suppliers for goods or services received but not yet paid for.
What is ALNYLAM PHARMACEUTICALS, INC.'s current accounts payable?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual accounts payable for 2025 was $115.7M, a 30.88% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. accounts payable for the quarter ending December 31, 2025 was $115.7M.
What was ALNYLAM PHARMACEUTICALS, INC.'s accounts payable in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual accounts payable for 2024 was $88.4M, a 59.25% increase from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s accounts payable in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual accounts payable for 2023 was $55.5M, a 43.40% decline from 2022.
What is ALNYLAM PHARMACEUTICALS, INC.'s 5-year accounts payable CAGR?
ALNYLAM PHARMACEUTICALS, INC. accounts payable grew at a compound annual growth rate (CAGR) of 17.36% from FY2020 to FY2025, going from $52.0M to $115.7M over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $115.7M | +30.9% | 10-K |
| FY2024 | $88.4M | +59.3% | 10-K |
| FY2023 | $55.5M | -43.4% | 10-K |
| FY2022 | $98.1M | +33.6% | 10-K |
| FY2021 | $73.4M | +41.3% | 10-K |
| FY2020 | $52.0M | +4.2% | 10-K |
| FY2019 | $49.9M | -16.5% | 10-K |
| FY2018 | $59.7M | +110.6% | 10-K |
| FY2017 | $28.4M | -47.9% | 10-K |
| FY2016 | $54.5M | +224.4% | 10-K |
| FY2015 | $16.8M | +11.1% | 10-K |
| FY2014 | $15.1M | +156.3% | 10-K |
| FY2013 | $5.9M | +33.4% | 10-K |
| FY2012 | $4.4M | -23.8% | 10-K |
| FY2011 | $5.8M | -37.7% | 10-K |
| FY2010 | $9.3M | -25.4% | 10-K |
| FY2009 | $12.5M | - | 10-K |